欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FR/V/0335/001
药品名称Rispoval RS+Pi3 IntraNasal
活性成分
    • Bovine Parainfluenza 3 Virus (pi3), RLB103, attenuated 10.0 ml
    • Bovine Respiratory Syncytial Virus (BRSV), strain 375 attenuated 10.0 ml
剂型Injection
上市许可持有人Zoetis UK Limited 5th Floor, 6 St Andrew Street London EC4A 3AE
参考成员国 - 产品名称France (FR)
互认成员国 - 产品名称
    • Romania (RO)
    • United Kingdom (Northern Ireland) (XI)
      Rispoval RS+Pi3 IntraNasal
    • Germany (DE)
    • Belgium (BE)
      Rispoval RS+Pi3 Intranasal
    • Netherlands (NL)
    • Luxembourg (LU)
    • Ireland (IE)
    • Austria (AT)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
    • Hungary (HU)
    • Czechia (CZ)
    • Slovakia (SK)
    • Slovenia (SI)
许可日期2008/04/05
最近更新日期2024/09/24
药物ATC编码
    • QI02AD07 bovine respiratory syncytial virus + bovine parainfluenza virus
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase